Anderson Ilona, Weichbold Viktor, D'Haese Patrick
Clinical Research Department, MED-EL, Fürstenweg 77, Innsbruck 6020, Austria.
Ear Nose Throat J. 2002 Apr;81(4):229-33.
Cochlear implantation is a viable treatment for patients with severe to profound hearing loss. We report the results of speech perception tests (numbers, monosyllables, and sentence tests) achieved with MED-EL's COMBI40+ (C40+) cochlear implant after 12 months of use. These findings, which were taken from a larger German study, were similar to those of other studies of the C40+ implant. We also compared the differences in speech perception observed with the CIS PRO+ body-worn speech processor and the newer TEMPO+ behind-the-ear speech processor. Although these results were similar with respect to most of the measured parameters, the TEMPO+ processor had a distinct advantage during tests in noise.
